Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
88.87
(
0.00%
)
Bitcoin
77,107.51
(
-0.04%
)
News Focus
News Focus
Post# of 445268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 590
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: Steges post# 21641

Tuesday, 07/17/2012 3:36:09 PM

Tuesday, July 17, 2012 3:36:09 PM

Post# of 445268
As I envision 'Third Party Funding" Elite licenses and makes ELI-216 Morphine for Watson/Actavis in exchange for Watson/Actavis funding the ELI-216 Phase III trials of $6 to $7 mil.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ELTP News
More ELTP News